Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

The ABCLEAR analysis was based on existing data that was submitted.

from homless Economist:

The only reason why I suspect they may be able to introduce some new data is because the MABs did precisely that in their re-examination (if you read their opinions), but it does appear on its face contrary to the guidance.

I dont think the data was new, the analysis was new. the data is the trial results from each patient. Wasnt ABCLEAR an analysis of a subset of this data? there was no new trial. So it should be oK